(Q38460680)

3 September 2017

title

A randomized, controlled trial of gabapentin enacarbil in subjects with neuropathic pain associated with diabetic peripheral neuropathy (English)

1 reference

3 September 2017

0 references

0 references

Richard Rauck

1

1 reference

3 September 2017

Clare W Makumi

2

1 reference

3 September 2017

Sherwyn Schwartz

3

1 reference

3 September 2017

Ole Graff

4

1 reference

3 September 2017

Guy Meno-Tetang

5

1 reference

3 September 2017

Christopher F Bell

6

1 reference

3 September 2017

Sarah T Kavanagh

7

1 reference

3 September 2017

Carrie L McClung

8

1 reference

3 September 2017

publication date

27 November 2012

1 reference

3 September 2017

1 reference

3 September 2017

volume

13

1 reference

3 September 2017

issue

6

1 reference

3 September 2017

page(s)

485-496

1 reference

Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study.

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12014

The Prevalence of Diabetic Distal Sensory Neuropathy in an English Community

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12014

A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12014

New perspectives on the management of diabetic peripheral neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12014

Clinical pharmacokinetics of XP13512, a novel transported prodrug of gabapentin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12014

Pharmacologic management of neuropathic pain: evidence-based recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12014

Recommendations for the pharmacological management of neuropathic pain: an overview and literature update

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12014

Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12014

Gabapentin in the treatment of painful diabetic neuropathy: a placebo controlled, double blind, crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12014

Placebo and treatment group responses in postherpetic neuralgia vs. painful diabetic peripheral neuropathy clinical trials in the REPORT database

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12014

Gabapentin for acute and chronic pain

21 January 2018

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1002/14651858.CD005452

Identifiers

DOI

10.1111/PAPR.12014

1 reference

3 September 2017

1 reference